Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,209,289 papers from all fields of science
Search
Sign In
Create Free Account
Total Androgen Blockade
Therapy used to eliminate male sex hormones (androgens) in the body. This may be done with surgery, hormonal therapy, or a combination.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.
D. Robinson
,
G. Sandblom
,
+4 authors
E. Varenhorst
Journal of Urology
2008
Corpus ID: 19984943
2008
2008
Métastase choroïdienne d’un adénocarcinome de la prostate : iconographie d’un cas rare
V. Primavera
,
G. Querques
,
+4 authors
N. D. Noci
2008
Corpus ID: 72031015
2003
2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
A. Pollack
,
D. Grignon
,
+7 authors
W. Shipley
Journal of Clinical Oncology
2003
Corpus ID: 19908113
PURPOSE DNA ploidy has consistently been found to be a correlate of prostate cancer patient outcome. However, a minority of…
Expand
2003
2003
Hormonal therapy for patients with advanced adenocarcinoma of the prostate: is there a role for discontinuing treatment after prolonged androgen suppression?
Roberto Pedraza
,
A. Kwart
Urology
2003
Corpus ID: 35794940
2001
2001
Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma
B. Szende
,
B. Szende
,
+10 authors
A. Végh
The Prostate
2001
Corpus ID: 42434079
Apoptosis is one of the major events following total androgen blockade (TAB). The aim of this study was to determine the…
Expand
1997
1997
PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients.
Willem Oosterlinck
,
J. Mattelaer
,
J. Casselman
,
R. V. Velthoven
,
M. Derde
,
Leonard Kaufman
Acta urologica Belgica
1997
Corpus ID: 7261013
OBJECTIVES To study the prognostic value of the prostate-specific antigen (PSA) response and its relationship with other initial…
Expand
1997
1997
[Total androgen blockade for prostate cancer].
Y. Kagebayashi
,
S. Ozono
,
+6 authors
E. Okajima
Hinyokika kiyo. Acta urologica Japonica
1997
Corpus ID: 36072556
To evaluate the usefulness of total androgen blockade (TAB) therapy, we retrospectively studied 45 patients with prostate cancer…
Expand
Review
1997
Review
1997
Treatment of metastatic carcinoma of the prostate.
H. Goethuys
,
L. Baert
,
H. Van Poppel
,
G. Lieskovsky
,
L. Brady
,
Z. Petrovich
American Journal of Clinical Oncology
1997
Corpus ID: 24722288
Disseminated carcinoma of the prostate (CaP) is a common manifestation of this disease. Metastatic CaP in the United States is…
Expand
Review
1991
Review
1991
Total androgen ablation: Canadian experience.
Gilles Béland
,
M. Elhilali
,
+5 authors
H. D. Tewari
Urologic clinics of North America
1991
Corpus ID: 43904768
A multicenter randomized, double-blind trial comparing total androgen blockade obtained by the use of castration with a pure anti…
Expand
Review
1988
Review
1988
Advantages of total androgen blockade in the treatment of advanced prostate cancer.
J. Geller
,
J. Albert
,
A. Vik
Seminars in Oncology
1988
Corpus ID: 11337055
Total androgen blockade has been proposed as a better therapeutic technique than castration alone for the management of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required